Related Experiment Videos
Rapid heterozygote detection in Glanzmann's thrombasthenia
W J Sharp1, U D Khanduri, B S Christie
1Department of Haematology, College of Medicine, Sultan Qaboos University, Oman.
British Journal of Haematology
|May 12, 1998
Summary
Flow cytometry effectively detects Glanzmann
Area of Science:
- Hematology
- Immunology
- Genetics
Background:
- Glanzmann's thrombasthenia (GT) is a rare inherited bleeding disorder.
- Accurate identification of heterozygote carriers is crucial for genetic counseling.
- Current diagnostic methods for heterozygotes can be challenging.
Purpose of the Study:
- To evaluate flow cytometric analysis of platelet glycoprotein IIb (GPIIb) for detecting Glanzmann's thrombasthenia heterozygotes.
- To compare fluorescence intensity of anti-CD41-labeled platelets in heterozygotes versus normal subjects.
Main Methods:
- Flow cytometric analysis of anti-CD41-labeled platelets.
- Comparison of relative fluorescence intensity between obligatory heterozygotes and normal individuals.
- Inclusion of mean platelet volume as a correction factor for platelet size.
Main Results:
- Initial analysis showed overlapping fluorescence intensity between normal subjects and heterozygotes.
- Incorporating mean platelet volume as a correction factor eliminated this overlap.
- Flow cytometry demonstrated potential for differentiating heterozygote carriers.
Conclusions:
- Flow cytometric analysis of platelet GPIIb, corrected for mean platelet volume, can reliably detect Glanzmann's thrombasthenia heterozygotes.
- This method offers a rapid and confident approach for carrier status prediction in families affected by GT types I and II.